Value Competitors

PLTF Stock

ILS 21.60 0.70 3.35%

Value Capital One competes with Seach Medical, Imed Infinity, Rapac Communication, Hiron Trade, and ICL Israel; as well as few others. The company operates under Real Estate Management & Development sector and is part of Real Estate industry. Analyzing Value Capital competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Value Capital to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Value Capital Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Value Capital competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
18.30	21.60	24.90

Details

Intrinsic

Valuation

Low	Real	High
15.24	18.54	21.84

Details

Value Capital Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Value Capital and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Value and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Value Capital One does not affect the price movement of the other competitor.

	SEMG	IMED	MTRD	RPAC	HRON	ICL	BVC	IARG
SEMG		-0.67	0.95	0.78	0.88	0.81	-0.86	-0.36	SEMG
IMED	-0.67		-0.64	-0.62	-0.62	-0.55	0.62	0.48	IMED
MTRD	0.95	-0.64		0.62	0.81	0.77	-0.86	-0.2	MTRD
RPAC	0.78	-0.62	0.62		0.82	0.8	-0.66	-0.43	RPAC
HRON	0.88	-0.62	0.81	0.82		0.83	-0.74	-0.42	HRON
ICL	0.81	-0.55	0.77	0.8	0.83		-0.7	-0.1	ICL
BVC	-0.86	0.62	-0.86	-0.66	-0.74	-0.7		0.39	BVC
IARG	-0.36	0.48	-0.2	-0.43	-0.42	-0.1	0.39		IARG
	SEMG	IMED	MTRD	RPAC	HRON	ICL	BVC	IARG

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

MTRD	+ 0.95	SEMG
HRON	+ 0.88	SEMG
ICL	+ 0.83	HRON
HRON	+ 0.82	RPAC
ICL	+ 0.81	SEMG
HRON	+ 0.81	MTRD

High negative correlations

BVC	- 0.86	MTRD
BVC	- 0.86	SEMG
BVC	- 0.74	HRON
BVC	- 0.7	ICL
IMED	- 0.67	SEMG
BVC	- 0.66	RPAC

Risk-Adjusted Indicators

There is a big difference between Value Stock performing well and Value Capital Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Value Capital's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SEMG	1.53	0.79	0.43	2.11	0.89	(1.77)	4.47	(2.78)	14.14
IMED	0.88	(0.19)	0.00	0.52	0.00	0.00	2.24	(4.98)	12.35
MTRD	1.02	0.41	0.33	(3.51)	0.63	(1.25)	2.44	(2.09)	6.92
RPAC	1.08	0.22	0.15	6.56	1.06	(1.31)	2.96	(2.33)	7.88
HRON	0.69	0.12	0.05	(0.44)	0.76	(1.54)	2.27	(1.88)	5.71
ICL	1.85	0.15	0.07	12.93	1.85	(2.07)	4.55	(3.16)	11.77
BVC	1.47	(0.14)	0.00	(1.09)	0.00	0.00	3.56	(3.64)	11.01
IARG	2.69	(0.33)	0.00	(1.76)	0.00	0.00	5.08	(6.60)	22.07

Unable to evaluate fundamental data of [SEMG.TA, IMED.TA, MTRD.TA, RPAC.TA, HRON.TA, ICL.TA, BVC.TA, IARG.TA] at this time. Please try again later

All Fundamental Data

Value Capital Competitive Analysis

The better you understand Value Capital competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Value Capital's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Value Capital's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	PLTF	SEMG	IMED	MTRD	RPAC	HRON	ICL	BVC	IARG
	3.35 21.60 Value	2.78 303.70 Seach	4.14 103.20 Imed	0.36 1,118 Meitav	2.33 2,849 Rapac	2.98 227,300 Hiron	1.71 1,780 ICL	1.73 88.20 Batm	4.46 79.70 Iargento
Market Volatility (90 Days Market Risk)	Not too volatile	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Insignificant	Strong	Very Weak	Very Strong	Good	Good	OK	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Quite High	Low	Below Average	Unknown	Low	Low	Low	Below Average	About Average
Current Valuation (Equity Enterprise Value)	Over Valued	Under Valued	Over Valued	Over Valued	Under Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Buy	Strong Sell	Hold	Strong Buy	Sell	Strong Hold	Strong Sell	Strong Sell
Current Ratio	1.04	6.78	N/A		1.21	0.32	1.52	2.11	N/A
Net Asset	N/A	N/A	N/A		3.17 B	1.19 B	11.08 B	193.16 M	N/A
Profit Margin	-2.06	0.0463	N/A		0.045	0.97	0.21	0.0199	N/A
EBITDA	(980 K)	11.16 M	N/A		245.53 M	166.43 M	1.8 B	31.06 M	N/A
Operating Margin	-1.39	0.069	-12.33		0.0808	0.38	0.34	-0.0589	N/A
Current Valuation	N/A	N/A	N/A		2.4 B	977.03 M	43.75 B	267.15 M	N/A
Price To Book	N/A	N/A	N/A		1.46	0.96	2.0	0.95	N/A
Retained Earnings	N/A	N/A	N/A		(10 M)	473 M	2.5 B	(306 M)	N/A
Current Asset	N/A	N/A	N/A		293 M	53 M	2.98 B	78 M	N/A
Five Year Return	N/A	N/A	N/A		8.65	1.06	3.53	N/A	N/A
Beta	1.25	0.28	-0.13		0.45	0.38	0.41	0.32	N/A
Number Of Employees	1	74	45		565	30	12.5 K	1.02 K	N/A
Shares Outstanding	53.95 M	34.02 M	N/A		15.33 M	481.16 K	1.29 B	436.04 M	N/A
Cash Flow From Operations	(3.39 M)	(8.87 M)	N/A		205.55 M	41.67 M	1.06 B	5.59 M	N/A
Annual Yield	N/A	N/A	N/A		0.0177	0.0206	0.12	0.0317	N/A
Total Debt	33.16 M	1.93 M	N/A		2.08 B	112.21 M	2.44 B	1.36 M	N/A
Return On Equity	N/A	0.0488	-0.0681		0.46	0.15	0.43	0.028	N/A
Z Score	0.6	25.8	N/A		N/A	4.8	8.4	N/A	N/A
Return On Asset	-0.14	0.0416	-0.049		0.025	0.0285	0.19	-0.0251	N/A
Book Value Per Share	0.037	3.19	2.52		21.98	1972.71	4.12	0.27	N/A
Current Liabilities	N/A	N/A	N/A		199 M	131 M	2.05 B	30 M	N/A
Total Asset	N/A	N/A	N/A		3.17 B	1.19 B	11.08 B	193.16 M	N/A
Debt To Equity	424.8	0.023	N/A		309.9	0.14	0.67	7.0	N/A
Last Dividend Paid	N/A	N/A	N/A		0.55	40.0	0.9	N/A	N/A
Target Price	N/A	N/A	N/A		N/A	N/A	9.13	N/A	N/A
Shares Owned By Institutions	N/A	5.48	42.08		32.83	7.57	25.12	40.2	N/A
Market Capitalization	47.21 M	83.4 M	5.25 M		432.67 M	934.89 M	34.72 B	529.43 M	N/A
Price To Earning	871.79	N/A	N/A		242.78	915.6	N/A	N/A	N/A
Price To Earnings To Growth	N/A	N/A	N/A		N/A	N/A	168.1	N/A	N/A
Price To Sales	N/A	1.4	88.55		0.33	6.2	3.31	3.35	N/A
Net Income	(11.71 M)	13.49 M	N/A		32.31 M	127.55 M	783 M	14.34 M	N/A
Earnings Per Share	-0.11	0.19	-0.19		4.23	340.27	5.67	0.02	N/A
Shares Owned By Insiders	64.44	64.06	20.9		51.24	81.66	44.9	26.28	23.66
Revenue	5.29 M	124.68 M	75 K		1.2 B	245.19 M	6.96 B	140.04 M	N/A
Working Capital	N/A	N/A	N/A		94 M	(78 M)	939 M	48 M	N/A
Cash And Equivalents	234 K	22.01 M	N/A		89.02 M	234 K	492 M	24.39 M	N/A
Cash Per Share	N/A	0.07	N/A		6.38	0.59	0.38	0.06	N/A
Gross Profit	7.62 M	23 M	75 K		168.12 M	78.94 M	2.61 B	51.06 M	N/A
Day Typical Price	21.43	304.97	103.27	1121.33	2845.67	227300.0	1775.67	87.7	79.67
Accumulation Distribution	0.0413	0.0233	0.0039	0.0246	0.044	N/A	0.0162	0.017	0.0667
Market Facilitation Index	0.9	7.2	0.4	28.0	128.0	N/A	29.0	1.5	5.5
Daily Balance Of Power	0.7778	(1.21)	10.25	0.1429	(0.53)	(9,223,372,036,855)	(1.07)	1.0	0.6182
Period Momentum Indicator	0.7	(8.70)	4.1	4.0	(68.00)	(6,970)	(31.00)	1.5	3.4
Rate Of Daily Change	1.03	0.97	1.04	1.0	0.98	0.97	0.98	1.02	1.04
Day Median Price	21.35	305.6	103.3	1123.0	2844.0	227300.0	1773.5	87.45	79.65
Price Action Indicator	0.6	(6.25)	1.95	(3.00)	(29.00)	(3,485)	(9.00)	1.5	1.75
Coefficient Of Variation	(1,692)	287.87	(1,052)	324.87	659.53	928.3	1477.6	(1,583)	(1,229)
Mean Deviation	2.78	1.53	0.8802	1.02	1.08	0.6887	1.85	1.47	2.69
Jensen Alpha	(0.25)	0.7941	(0.19)	0.4118	0.225	0.1236	0.1536	(0.14)	(0.33)
Total Risk Alpha	(0.34)	0.7375	(0.25)	0.3713	0.1824	0.0847	0.0865	(0.20)	(0.44)
Sortino Ratio	N/A	0.427	N/A	0.3307	0.1516	0.0529	0.0655	N/A	N/A
Downside Variance	N/A	3.34	N/A	1.37	1.8	3.26	4.05	N/A	N/A
Standard Deviation	3.82	2.34	1.94	1.36	1.55	1.19	2.42	2.05	3.92
Kurtosis	1.09	4.94	7.04	0.7294	1.93	3.42	1.41	1.7	1.29
Potential Upside	5.86	4.47	2.24	2.44	2.96	2.27	4.55	3.56	5.08
Treynor Ratio	(0.48)	2.11	0.5194	(3.51)	6.56	(0.44)	12.93	(1.09)	(1.76)
Maximum Drawdown	17.78	14.14	12.35	6.92	7.88	5.71	11.77	11.01	22.07
Variance	14.61	5.47	3.75	1.86	2.42	1.41	5.87	4.2	15.4
Market Risk Adjusted Performance	(0.47)	2.12	0.5294	(3.50)	6.57	(0.43)	12.94	(1.08)	(1.75)
Risk Adjusted Performance	(0.04)	0.2835	(0.07)	0.2495	0.1257	0.0891	0.0607	(0.04)	(0.06)
Skewness	0.1885	1.49	(1.14)	0.4222	0.597	0.2987	0.9868	(0.42)	0.2849
Semi Deviation	N/A	0.8868	N/A	0.6305	1.06	0.7577	1.85	N/A	N/A
Information Ratio	(0.07)	0.3336	(0.11)	0.2842	0.1309	0.0806	0.0544	(0.08)	(0.09)
Value At Risk	(6.28)	(2.78)	(4.98)	(2.09)	(2.33)	(1.88)	(3.16)	(3.64)	(6.60)
Expected Short fall	N/A	(1.77)	N/A	(1.25)	(1.31)	(1.54)	(2.07)	N/A	N/A
Downside Deviation	N/A	1.83	N/A	1.17	1.34	1.81	2.01	N/A	N/A
Semi Variance	N/A	0.7864	N/A	0.3976	1.13	0.5741	3.42	N/A	N/A

Value Capital Competition Performance Charts

Five steps to successful analysis of Value Capital Competition

Value Capital's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Value Capital One in relation to its competition. Value Capital's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Value Capital in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Value Capital's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Value Capital One, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Value Capital position

In addition to having Value Capital in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Target Outcome ETFs Thematic Idea Now

Target Outcome ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 92 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Value Stock

Value Capital financial ratios help investors to determine whether Value Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Value with respect to the benefits of owning Value Capital security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC